Y-mAbs Therapeutics Inc
YMAB·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$8.61
Today
+0.0%
YTD
+0.3%
About
Y-mAbs Therapeutics Inc is an American clinical biopharmaceutical company engaged in the development and commercialisation of antibody-based therapeutics. These products are used in the treatment of cancers. The firm, founded in 2015, is headquartered in New York City, and trades on the NASDAQ GS under the ticker YMAB. Add this instrument to your eToro watchlist to stay up to date on the latest YMAB price charts.
Price chart
Closing price history for YMAB (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-17.40
P/S (TTM)4.57
P/B (TTM)4.47
Market cap$391.22M
Cap tierSmall-cap
Industry avg P/E-6.24
Profitability
Gross margin81.73%
EBIT margin-31.21%
Net margin-16.59%
ROE-24.31%
ROA-17.01%
Earnings & Revenue
Revenue (TTM)$85.39M
Revenue growth (1Y)-1.3%
EPS (TTM)-$0.49
Free cash flow$-17.92M
Total debt$3.12M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.46
Employees107
Next earnings6 Nov '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.